Michael Ashburn, M.D., M.P.H.

Professor of Anesthesiology and Critical Care Medicine; Director, Pain Medicine and Palliative Care
University of Pennsylvania

Fellowship Profile

Fellowship Year: 1995-1996
Fellowship Placements: Sen Hatch (R-UT), Senate Committee on the Judiciary
Sponsoring Institution: University of Utah School of Medicine
Discipline / Profession: Critical Care/Anesthesia

Biography

Michael A. Ashburn, MD, MPH, MBA

Dr. Ashburn is professor of Anesthesiology and Critical Care, and a Senior Fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He is the Director of the Penn Pain Medicine Center and was named to the Penn Academy of Master Clinicians in 2014.

Dr. Ashburn completed his undergraduate training at Auburn University in physics, his MPH at the University of Utah, his MBA at the Wharton School of Business at the University of Pennsylvania, and his medical training at the University of South Alabama in Mobile, Alabama. He completed his residency in anesthesiology at the University of South Alabama Medical Center, and a fellowship in pain medicine at the University of Utah. He is board certified in Anesthesiology, Pain Management, Hospice and Palliative Medicine through the American Board of Anesthesiology, and in Addiction Medicine through the American Board of Preventive Medicine.

Dr. Ashburn was a member of the Department of Anesthesiology at the University of Utah from 1987 – 2002 and served as Professor of Anesthesiology and Director of the Pain Management Center from 1996 - 2002. Dr. Ashburn was president of the American Pain Society from 2000 - 2002. In addition, Dr. Ashburn served on the Board of Directors of the Rehabilitation Accreditation Commission, (CARF) from 2001-2003, where he served as a member of 3 National Advisory Committees on Pain. Prior to joining the faculty at the University of Pennsylvania in 2007, Dr. Ashburn was the co-founder and Executive Vice President for Clinical and Regulatory Affairs for ZARS Pharma of Salt Lake City.

Dr. Ashburn was a Robert Wood Johnson Health Policy Fellow from 1995 - 1996, where he served as a health policy advisor for Senator Orrin Hatch (R, UT) in Washington, DC. He served as the Chairman of the Pain Care Coalition from 2000-2002, and as the chair of the Pennsylvania Pain Coalition from 2009 to 2012. Dr. Ashburn has served as an expert witness for the Drug Enforcement Agency, Federal Bureau of Investigation, and Department of Justice, as well as the states of Maryland and Pennsylvania.

Dr. Ashburn served on the Pennsylvania House Advisory Committee on Opioid Addiction (2014-2015), the Pennsylvania task force to develop core competencies for the prevention and management of prescription drug abuse for use by Pennsylvania medical schools (2016- 2017, revised in 2020), and the Pennsylvania Legislative Advisory Committee on Addiction Treatment Services (2016 - 2018). Dr. Ashburn currently serves on the Pennsylvania State Task Force on Prescription Drug Abuse and the Advisory Board for the Pennsylvania Prescription Drug Monitoring Database. Dr. Ashburn has been the senior author or a member of the committee that developed 15 Pennsylvania state guidelines related to the treatment of pain, proper use of opioids, or the treatment of addiction.

Dr. Ashburn serves on the editorial board for Pain Medicine and The Journal of Opioid Management. He has been active in clinical research, mainly centered on the development of outcome measurement systems for chronic pain and palliative care, the integration of specialty care into primary care practice through the patient-centered medical home model of care, the study of non-invasive drug delivery systems, and the conduct of safety and efficacy trials intended to evaluate a drug or device for the treatment of pain. This has led to over 130 publications. He is a co-principle investigator for the University of Pennsylvania clinical trial hub site for the Early Phase Pain Investigation Clinical Network (EPPIC-NET) program sponsored by the NIH (2019 – present).
(Updated 8/6/2021)